Residencies and Fellowships

GSK has a rich history of collaboration with leading US academic institutions through sponsorship of joint fellowship programs. Currently, our programs focus on Medical Affairs, Regulatory Affairs, Pharmaceutical Outcomes Research, and drug/medical information. Most graduates of these programs have gone on to successful industry and/or academic careers.

We sponsor fellowship and residency opportunities with two major North Carolina universities: UNC-Chapel Hill and Duke.

Core areas of study include:

  • US Medical Affairs Fellowship (UNC; PharmD or PhD; 2 years)
  • Regulatory Affairs Fellowship (UNC; PharmD, PhD, or MD; 2 years)
  • Pharmaceutical Outcomes Research Fellowship (UNC; PharmD, PhD, or MD; 2 years)
  • Drug/Medical Information Residency (Duke; PharmD; 1 year)

US Medical Affairs Fellowship (PharmD or PhD)

The US Medical Affairs fellowship at GSK provides the practical training and experience needed to compete successfully for positions in the pharmaceutical industry, academia, clinical practice, and contract research organizations (CROs).

The first year of the fellowship at UNC will be focused on understanding the principles of clinical research, including the important concepts of Good Clinical Practice and how they relate to the wellbeing of study subjects, data collection, analysis, and reporting. In addition, fellows will understand and apply various clinical design strategies, evaluate research designs and reports, employ biostatistical tests, develop a protocol, recruit and monitor patients or subjects, collect and analyze data, and prepare a manuscript from the academic perspective.

Fellows will spend the second year at GSK within US Medical Affairs and gain an understanding of the decision-making process that healthcare providers and payers follow for the utilization of approved pharmaceuticals. They will understand the laws, regulations, and policies required to ensure appropriate interactions with healthcare professionals and gain clinical proficiency and deep product expertise in a therapeutic area.

At GSK, fellows will work in a cross-functional USMA matrix team which includes the US Medical Affairs Lead, therapy area scientific/medical directors, medical information, medical science liaisons, health outcome liaisons, and US Value evidence outcomes. The fellow will also collaborate with global medical affairs, global clinical safety and pharmacovigilance, regulatory affairs, legal, health outcomes, research and development, and commercial.

The fellowship will provide experience and training in:

  • Contributing to the development and execution of the US Medical Affairs Plan and the medical content of launch plans
  • Integrating the voice of the US customer (patients, providers, payers) into medical affairs strategy
  • Understandig, interpreting, and applying external knowledge in medical plans
  • Conducting strategic reviews of the medical literature and the competitive environment to identify data and educational gaps to enhance patient care
  • Contributing to US scientific engagement between GSK and external communities to advance scientific and medical understanding of the management of disease(s) and the use of our medicines
  • Participating in the medical review of promotional materials and preparation of medical support for congress materials

Application Process

US Medical Affairs

The 2-year fellowships begin on July 1st. See for instructions on submitting an application. The deadline for early consideration is November 15th. The final deadline to apply is January 1st. Early applications are encouraged.

Global Regulatory Affairs Fellowship (PharmD, PhD, or MD)

The Global Regulatory Affairs (GRA) Fellowship provides practical training and experience in Regulatory Affairs to help fellows gain expertise in regulatory requirements and strategy pertinent to drug development. Through a combination of academic and industry training, the fellow will develop an indepth understanding of Global Regulatory Affairs and the drug development process from pre-clinical to post-marketing stages. Fellows will establish a strong foundation to successfully compete for career opportunities in the pharmaceutical industry, academia, Food and Drug Administration (FDA), and contract research organizations (CROs).

In the first 6 months, fellows will spend 2-3 days a week at the UNC, working alongside the Institute for Global Health and Infectious Disease and the UNC Lineberger Comprehensive Cancer Center. During this time, fellows will gain postgraduate didactic and development opportunities with a focus on Regulatory Affairs, drug development, and clinical trial conduct. Fellows will spend the remainder of the week at GSK within the Regulatory Affairs department.

Fellows will gain real-world experience in the Global Regulatory Affairs department at GSK, gaining hands-on opportunities across the many phases of drug development. The guidance and support from GRA mentors and experts ensure our fellows will develop valuable regulatory strategic skills and be ready to function as an effective project team leader in drug development.

The fellowship will provide experience and training in:

  • Didactic courses: US and EU Regulatory Affairs Certification (RAC) Workshops, Drug Development, Clinical Trial Design, Leadership
  • Apply principles of pharmaceutical product development and evaluation
  • Review study protocols, patient consent forms, IRB applications, and safety assessment reports
  • Interact with regulatory agencies worldwide to facilitate product development
  • Develop regulatory strategy by using and interpreting regulations and guidelines
  • Understand the requirements and mechanics of IND, NDA, and maintenance submissions as well as the regulatory agency review processes in the US, Europe, and rest of the world
  • Prepare regulatory interaction documents and submission packages
  • Additional development opportunities in regulatory medical devices/diagnostics, labeling, advertising and promotion, and regulatory intelligence
  • Potential rotational opportunity at the Food and Drug Administration (FDA)

Application Process

Global Regulatory Affairs

The 2-year fellowships begin on July 1st. See for instructions on submitting an application. The deadline for early consideration is November 15th. The final deadline to apply is January 1st. Early applications are encouraged.

Pharmaceutical Outcomes Research Fellowship (PharmD, PhD, or MD)

The Pharmaceutical Outcomes Research Fellowship is designed as a partnership between the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy and the US Values, Evidence, and Outcomes group at GSK. Fellows will be provided the training and experience needed to compete successfully for positions as a health outcomes researcher in consulting groups, managed care, academia, and the pharmaceutical industry. The ideal candidate should possess strong analytical skills, excellent written and verbal communication, good organizational abilities, and evidence of leadership and teamwork. A background and strong interest in outcomes research is preferred.

In the first year, fellows will spend approximately 80% of their time at UNC supplementing their didactic education. Fellows are provided opportunities to learn the science of health services research and then apply those learnings to research projects at both UNC and GSK. This applied training program integrates science into leadership, communication, and strategic thinking skills while working within research teams. Depending on each fellows’ interests, training will be received through courses related to research methods, statistics, pharmacoepidemiology, pharmaceutical policy, and/or pharmacoeconomics. The fellow will also have opportunities to design and conduct various research projects under the mentorship of faculty at the UNC Eshelman School of Pharmacy.

Fellows will spend approximately 80% of their second year at GSK in the US Values, Evidence, and Outcomes group. While at GSK, the fellow will apply health outcomes research methodology and engage in strategy discussions across various groups within US Medical Affairs. The fellow will concentrate on improving the competency in generation of health outcomes evidence related to US marketed pharmaceuticals and therapy areas. In addition, the program will emphasize strategic thinking, working within a matrix, understanding the US payer environment, communication of evidence to external and internal customers, and study conduct.

Fellows will have additional opportunities to enroll in courses through UNC during the second year to further enhance their didactic understanding.

Application process

Pharmaceutical Outcomes Research

The fellowship will begin July 1, 2018. Interested applicants should submit a letter of interest, curriculum vitae, official transcript, and three letters of recommendation electronically by January 1, 2018 to the following email address:

Jessica Driscoll
Division of Pharmaceutical Outcomes and Policy

Drug/Medical Information Residency

This 12-month residency provides specialty drug information training in the GSK Medical Information Department at the Research Triangle Park, NC campus (6 months) with additional clinical and drug information experiences at Duke University Hospital (6 months).

The resident is a member of a therapeutic team at GSK, participating in activities that mirror those of a scientist. Activities for the resident include written and oral communication with healthcare professionals, evidence-based literature evaluation, product-specific database management, review of promotional materials, sales representative training, managed care dossier development and provision of medical expertise and support to various other departments within the company. 

The 943-bed Duke University Hospital is consistently rated as one of the top hospitals in the US.  Residents participate in clinical training and hospital-based drug information experiences at Duke University Hospital’s Department of Pharmacy, comprised of 240 full time employee positions.  Residents study and practice under the supervision of specialists in Drug Information, Medication Safety, Quality Improvement, Informatics, and Investigational Drugs. The residency strengthens competencies in literature evaluation, clinical trial design, drug policy management, medication safety, adverse drug event analysis and direct patient care.

Development of critical thinking skills, project management, presentation preparation and delivery are important focuses of the training. The resident will complete formal residency projects at both GSK and Duke University Hospital and will present them at national scientific meetings. Residents also have opportunities to teach various allied health professionals including medical, nursing, and physical therapy students as well as to precept PharmD candidates on rotation.

Application process

Drug/Medical Information Residency (PharmD)

The residency will begin July 1st. Application materials must be sent electronically by January 1st. For further information about the residency and application process please visit the Duke website.